Skip to main navigation
Toggle navigation
Facebook
Instagram
Twitter
Linkedin
Email
Company
Company Submenu
Company
Team
Management and Board
Scientific Advisory Board
Our Work
Our Pipeline
Our Pipeline Submenu
Our Pipeline
ACG-801 (Farber Disease)
ACG-701 (Melioidosis)
ACG-701 (Cystic Fibrosis)
Patient Info
Patient Info Submenu
Patient Info
Farber Disease
Melioidosis
Cystic Fibrosis
Contact Us
Investors
Investors & Media
Special Meeting of Stockholders
Press Releases
Investor Events
Corporate Governance
Stock Information
SEC Filings
Investor Information
Contact Us
Please direct all questions regarding Aceragen to:
Aceragen, Inc.
15 TW Alexander Drive
Durham, NC 27709
info@aceragen.com
Print Page
RSS Feeds
Email Alerts
Management & Directors
Highlights
Management & Directors
Committee Composition
Guidelines
Conduct
Management
John Taylor
Chief Executive Officer
Directors
Cristina Csimma, Pharm. D., M.H.P.
Michael Dougherty
Maxine Gowen, PhD
Vincent Milano
Chair of the Board
John Taylor
Chief Executive Officer
Ron Wooten
You are Leaving this Site
You are leaving investors.aceragen.com, a website provided [on behalf of /by] Aceragen.
